Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Pamela DiPiro, M.D.

Concepts (192)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Referral and Consultation5202336160.900 Why?
Oncology Service, Hospital22017550.670 Why?
Carcinoma, Lobular220204700.590 Why?
Abdominal Neoplasms120192850.560 Why?
Breast Neoplasms182023210620.510 Why?
Physician Assistants120181900.510 Why?
Mammography12201824230.490 Why?
Radiology4202320890.440 Why?
Neoplasms, Second Primary2201910560.420 Why?
Fibrocystic Breast Disease520001010.410 Why?
Tomography, X-Ray Computed132023206760.400 Why?
Biopsy, Needle8200016170.360 Why?
Academic Medical Centers5202327800.350 Why?
Lymphoma, Large B-Cell, Diffuse2201714350.310 Why?
Breast8200019470.300 Why?
Radiology Information Systems320215310.290 Why?
Cancer Care Facilities220184270.290 Why?
Inflammatory Breast Neoplasms220201500.280 Why?
Lymphoma, T-Cell120093080.270 Why?
Medical Oncology1201823400.260 Why?
Liver Neoplasms2202043500.260 Why?
Neoplasm Metastasis3201648840.250 Why?
Evidence-Based Medicine1201736870.240 Why?
Radiology Department, Hospital220194070.220 Why?
Ultrasonography, Mammary520182410.210 Why?
Magnetic Resonance Imaging72021365430.200 Why?
Genes, erbB-2220141600.200 Why?
Carcinoma, Ductal, Breast5202010840.190 Why?
Stereotaxic Techniques520005510.190 Why?
Fluorodeoxyglucose F182202020250.180 Why?
Forms and Records Control120201580.160 Why?
Incidental Findings220206960.150 Why?
Calcinosis5200014780.150 Why?
Multiple Pulmonary Nodules120201700.150 Why?
Calcium Phosphates120181710.140 Why?
Surgical Instruments119993790.140 Why?
Solitary Pulmonary Nodule120202760.140 Why?
Workload120028500.130 Why?
Environment1200211150.130 Why?
Retrospective Studies182023815220.130 Why?
Tumor Burden2201418890.130 Why?
Lung Neoplasms62020134550.130 Why?
Neoplasms52017223500.130 Why?
Quality Improvement3202038540.120 Why?
Foreign Bodies119994020.120 Why?
Immunoconjugates120239790.120 Why?
Seat Belts11995600.120 Why?
Humans5020237660110.120 Why?
Patient Care Planning120209060.120 Why?
Positron-Emission Tomography4201765450.110 Why?
Neoplasm Recurrence, Local4201793710.110 Why?
Receptors, Progesterone2202011520.110 Why?
Female3720233961590.100 Why?
Terminology as Topic1202015360.100 Why?
Clinical Protocols1201814410.100 Why?
Radiopharmaceuticals2202026990.100 Why?
Carcinoma, Intraductal, Noninfiltrating119999200.100 Why?
Receptor, erbB-23202325920.090 Why?
Genes, BRCA1120147530.090 Why?
Receptors, Estrogen2202022410.090 Why?
Interprofessional Relations120179990.090 Why?
Mucous Membrane120136560.090 Why?
Quinazolines2201413650.090 Why?
Breast Diseases319984360.090 Why?
Pleural Neoplasms120145830.080 Why?
Immunoblastic Lymphadenopathy12009400.080 Why?
Prognosis42019299150.080 Why?
Survival Analysis22019100860.080 Why?
Accidents, Traffic119958180.080 Why?
Contrast Media3201853300.080 Why?
Leukemia-Lymphoma, Adult T-Cell120091660.080 Why?
Neoplasm Staging72020112080.070 Why?
Middle Aged2520202230580.070 Why?
Pulmonary Embolism2201226000.070 Why?
Delivery of Health Care, Integrated120169540.070 Why?
Lymphoma, Large-Cell, Anaplastic120091680.070 Why?
Aged2120201712330.070 Why?
Follow-Up Studies62020392260.070 Why?
Nose Neoplasms120092490.070 Why?
Decision Support Techniques1201720030.070 Why?
Hodgkin Disease1201413830.070 Why?
Cone-Beam Computed Tomography120104450.070 Why?
Patient-Centered Care1201714580.070 Why?
Central Nervous System Neoplasms120149180.060 Why?
Adult2120202231090.060 Why?
Molecular Targeted Therapy1201728230.060 Why?
Melanoma2201456960.060 Why?
Diabetes Mellitus, Type 11199934440.060 Why?
Uterine Cervical Neoplasms1201620410.060 Why?
Carcinoma, Non-Small-Cell Lung2201453880.050 Why?
Carcinoma in Situ220007770.050 Why?
Aged, 80 and over92019595260.050 Why?
Antineoplastic Combined Chemotherapy Protocols22014118620.050 Why?
Radiation Injuries1201011810.050 Why?
Boston3201993410.050 Why?
Brachytherapy1201012210.050 Why?
Physicians1202045870.050 Why?
Mass Screening1201854480.050 Why?
Bone Neoplasms1201425640.050 Why?
Radiography2202369380.050 Why?
Iohexol220142050.050 Why?
Brain Neoplasms1202390710.050 Why?
Diagnosis, Differential32020129690.050 Why?
Gastrointestinal Stromal Tumors120056160.040 Why?
Camptothecin120236000.040 Why?
Antineoplastic Agents32017136390.040 Why?
Medical Record Linkage120192860.040 Why?
Radiographic Image Enhancement220148720.040 Why?
Workflow120228610.040 Why?
Treatment Outcome72023652360.040 Why?
Ultrasonography, Interventional2200215320.030 Why?
Negotiating120181520.030 Why?
Carcinoma, Squamous Cell1201240460.030 Why?
Radiographic Magnification11996180.030 Why?
Male1120173638080.030 Why?
Fibroadenoma11996400.030 Why?
Axilla120186150.030 Why?
Comprehensive Health Care120161230.030 Why?
Adenocarcinoma1201263610.030 Why?
Fat Necrosis11995580.030 Why?
Risk2201896000.030 Why?
Contusions11995780.030 Why?
Piperazines1200525460.030 Why?
Radiography, Interventional2199911300.030 Why?
Evaluation Studies as Topic1199616050.030 Why?
Data Collection1200233180.030 Why?
Pyrimidines1200530460.030 Why?
Antibodies, Neoplasm120142820.030 Why?
Lymph Node Excision1201812590.030 Why?
Models, Organizational120165490.020 Why?
Cysts119976840.020 Why?
Vinblastine120134830.020 Why?
Kaplan-Meier Estimate2201265080.020 Why?
Markov Chains120149670.020 Why?
Maytansine12011870.020 Why?
Mastectomy, Segmental119969640.020 Why?
Radiotherapy, Adjuvant1199617760.020 Why?
Biopsy2199967660.020 Why?
Mastectomy1201818470.020 Why?
Chemotherapy, Adjuvant1201835380.020 Why?
Ultrasonography2200059970.020 Why?
Skin Neoplasms1200958380.020 Why?
Estrogen Replacement Therapy1199612060.020 Why?
Vacuum22000640.020 Why?
Lymphocytes, Tumor-Infiltrating1201411040.020 Why?
Life Expectancy1201412490.020 Why?
Risk Factors12014748700.020 Why?
Neoadjuvant Therapy1201828940.020 Why?
Statistics, Nonparametric1201228460.020 Why?
Prospective Studies22023548180.020 Why?
Angiogenesis Inhibitors1201720460.020 Why?
Drug Administration Schedule1201448500.020 Why?
Lymphatic Metastasis1201328830.020 Why?
Radiation Dosage1201419440.020 Why?
Massachusetts1201888780.020 Why?
Cohort Studies22023416520.020 Why?
Decision Making1201839650.010 Why?
Observer Variation1201026110.010 Why?
Neovascularization, Pathologic1201426300.010 Why?
Survivors1201423740.010 Why?
Time Factors21996401170.010 Why?
Outpatients1201115930.010 Why?
Lymph Nodes1199334490.010 Why?
Dose-Response Relationship, Drug12014107310.010 Why?
Diagnostic Imaging1201635270.010 Why?
Cross-Sectional Studies12002262830.010 Why?
Cost-Benefit Analysis1201455280.010 Why?
Sex Factors12014106050.010 Why?
Biomedical Research1201634570.010 Why?
Recurrence1201285050.010 Why?
Early Detection of Cancer1201432370.010 Why?
Benzamides1200513760.010 Why?
Venous Thromboembolism1201218820.010 Why?
Multivariate Analysis12012120600.010 Why?
Automation120005850.010 Why?
Protein Kinase Inhibitors1201456930.010 Why?
Age Factors12014183840.010 Why?
Smoking1201490820.010 Why?
Hyperplasia1200011460.010 Why?
Image Processing, Computer-Assisted1201489270.010 Why?
Imaging, Three-Dimensional1201040360.010 Why?
Antibodies, Monoclonal1201492440.010 Why?
Anticoagulants1201248630.010 Why?
Reproducibility of Results12014201250.010 Why?
Chi-Square Distribution1200034360.010 Why?
Equipment Design1200034870.010 Why?
Incidence12011215070.010 Why?
Neoplasm Invasiveness1200035990.010 Why?
Lung12010100310.010 Why?
Young Adult12011598700.000 Why?
Case-Control Studies11997222300.000 Why?
Adolescent12005888040.000 Why?
DiPiro's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (192)
Explore
_
Co-Authors (63)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.